You are here:

NICE
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Psychosis and schizophrenia

Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

Technology appraisal guidance
Reference number: TA213
Published: 26 January 2011

Guidance
Tools and resources
Information for the public
History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders
23 May 2011
(60.41 Kb 17 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 17 May 2011